Money Talks in Hospitals’ Adoption of Oncology Biosimilars
Hospitals’ use of biosimilars for three major oncology drugs increased from 18-37% in 2020 to 84-93% in 2024.Hospitals’…
Dinutuximab beta plus chemotherapy shrinks neuroblastoma tumors in children
Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has…